We share experiences about the AI application MS sherpa with a patient, healthcare provider, healthcare administrator and innovator Orikami. MS sherpa has been developed for patients with MS (Multiple Sclerosis). To gain more insight, Orikami has developed two clinically validated tests, which use digital biomarkers to detect deterioration more quickly and apply the right treatment sooner. In addition to this closer introduction to MS sherpa, you will also gain insight into how other promising AI innovations can and should be implemented more widely.
During this day you can also network with other participants of the NL AIC, see the program. Sign In .